Cancer testis antigens in myelodysplastic syndromes revisited: a targeted RNA-seq approach

Cancer-Testis antigens (CTA) are named after the tissues where they are mainly expressed: in germinal and in cancer cells, a process that mimics many gametogenesis features. Mapping accurately the CTA gene expression signature in myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (C...

Descrición completa

Detalles Bibliográficos

Principais autores:	Ana María Hurtado López, Tzu Hua Chen-Liang, María Zurdo, Salvador Carrillo-Tornel, Joaquín Panadero, Eduardo José Salido, Victor Beltrán, Begoña Muiña, MariLuz Amigo, Noelia Navarro-Villamor, Rosa Cifuentes, Inés Calabria, Ana Isabel Antón, Raúl Teruel, Manuel Muro, Vicente Vicente, Andrés Jerez
Formato:	Artigo
Idioma:	Inglês
Publicado:	Taylor & Francis Group 2020-01-01
Series:	OncoImmunology
Assuntos:	cancer testis antigens azacitidine myelodysplastic syndromes t-cell response
Acceso en liña:	http://dx.doi.org/10.1080/2162402X.2020.1824642
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!